ADDITION OF AMPICILLIN/SULBACTAM & CIPROFLOXACIN— 510(k) K880617

Substantially Equivalent

Pasco Laboratories, Inc.

FDA 510(k) clearance K880617 for ADDITION OF AMPICILLIN/SULBACTAM & CIPROFLOXACIN, Substantially Equivalent on 1988-03-16. Applicant: Pasco Laboratories, Inc..

Clearance details

Applicant: Pasco Laboratories, Inc.
Product code: Code JWY
Advisory panel: Microbiology
Date received: 1988-02-16
Decision date: 1988-03-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Wheat Ridge, CO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.